James Hassard Crinetics Pharmaceuticals, Inc. (CRNX) insider trading activity

James Hassard is Chief Commercial Officer of Crinetics Pharmaceuticals, Inc.. Currently has a direct ownership of 29,259 shares of CRNX, which is worth approximately $1.57 Million. The most recent transaction as insider was on Jul 05, 2024, when has been sold 15,000 shares (Common Stock) at a price of $44.08 per share, resulting in proceeds of $661,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.3K

0% 3M change

108.99% 12M change

Total Value Held $1.57 Million

James Hassard Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 05 2024	SELL Open market or private sale	$661,200 $44.08 p/Share	15,000 Reduced 33.89%	29,259 Common Stock
Jul 05 2024	BUY Exercise of conversion of derivative security	$295,950 $19.73 p/Share	15,000 Added 25.31%	44,259 Common Stock
Jun 21 2024	SELL Open market or private sale	$669,900 $44.66 p/Share	15,000 Reduced 33.89%	29,259 Common Stock
Jun 21 2024	BUY Exercise of conversion of derivative security	$295,950 $19.73 p/Share	15,000 Added 25.31%	44,259 Common Stock
Mar 18 2024	SELL Payment of exercise price or tax liability	$66,401 $38.14 p/Share	1,741 Reduced 5.62%	29,259 Common Stock
Mar 04 2024	BUY Grant, award, or other acquisition	-	17,000 Added 35.42%	31,000 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	14,000 Added 50.0%	14,000 Common Stock

Also insider at

ARWR

ARROWHEAD PHARMACEUTICALS, INC. Healthcare

Chief Commercial Officer

James Hassard

Chief Commercial Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRNX shares.

Notify only if

Value

Insider Trading

Get notified when an Crinetics Pharmaceuticals, Inc. insider buys or sells CRNX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Crinetics Pharmaceuticals, Inc.

Track Activities on CRNX

Account